BerGenBio

Remuneration Information • Feb 13, 2018

BerGenBio ASA: Exercise of employee share options and increase of capital

Bergen, Norway, 13 February 2018 – The Board of Directors in BerGenBio ASA (the "Company") (OSE: BGBIO) has, to fulfil the Company's obligations under the option agreements, resolved to increase the Company's share capital by NOK 1,000 by issuance of 10,000 new shares. The new shares shall be subscribed for by an employee that wishes and is entitled to exercise options in accordance with the Company's option scheme. The subscription price shall be in accordance with the prevailing options price pursuant to the Company´s option scheme, ie NOK 24.00 per share. The shares shall be subscribed for in a separate subscription document in the period from 13. February 2018 and up to and including 27. February 2018.

-End-

Contacts

Richard Godfrey

CEO, BerGenBio ASA

+47 917 86 304

Tom Henrik Sundby

Finance Director, BerGenBio ASA

tom.sundby@bergenbio.com

+47 477 54 415

Forward looking statements

This announcement may contain forward-looking statements, which as such are not historical facts, but are based upon various assumptions, many of which are based, in turn, upon further assumptions. These assumptions are inherently subject to significant known and unknown risks, uncertainties and other important factors. Such risks, uncertainties, contingencies and other important factors could cause actual events to differ materially from the expectations expressed or implied in this announcement by such forward-looking statements

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.